Fred Grossman - 31 Jan 2024 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
31 Jan 2024
Net transactions value
$0
Form type
4
Filing time
02 Feb 2024, 20:00:19 UTC
Previous filing
19 Jul 2023
Next filing
05 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +81,819 $0.000000 81,819 31 Jan 2024 Common Stock, par value $0.0001 per share 81,819 $5.90 Direct F1
transaction COYA Stock Option (right to buy) Award $0 +74,069 $0.000000 74,069 31 Jan 2024 Common Stock, par value $0.0001 per share 74,069 $5.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.
F2 The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments.